IRIS UniCatt

Chiloiro, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.844
EU - Europa 1.524
AS - Asia 830
SA - Sud America 204
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.817
SG - Singapore 344
IT - Italia 332
DE - Germania 329
SE - Svezia 300
CN - Cina 245
BR - Brasile 185
IE - Irlanda 98
FR - Francia 97
ID - Indonesia 77
RU - Federazione Russa 63
PL - Polonia 58
UA - Ucraina 58
FI - Finlandia 53
GB - Regno Unito 44
IN - India 39
KR - Corea 23
HK - Hong Kong 22
BE - Belgio 21
CA - Canada 20
NL - Olanda 18
AT - Austria 16
TR - Turchia 15
JP - Giappone 13
IR - Iran 12
CI - Costa d'Avorio 8
LK - Sri Lanka 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
PT - Portogallo 5
AR - Argentina 4
CH - Svizzera 4
MX - Messico 4
PE - Perù 4
RO - Romania 4
VN - Vietnam 4
ES - Italia 3
IL - Israele 3
LT - Lituania 3
PK - Pakistan 3
AL - Albania 2
AZ - Azerbaigian 2
EC - Ecuador 2
GR - Grecia 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GU - Guam 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
NP - Nepal 1
OM - Oman 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.424
Salva come PNG Salva come JPEG
Città #
Chandler 410
Singapore 234
Ashburn 107
Rome 95
New York 91
Dublin 85
Ann Arbor 78
Jakarta 74
Fairfield 67
The Dalles 61
San Mateo 57
Milan 55
Warsaw 53
Wilmington 52
Bremen 44
Boston 41
Cattolica 40
Moscow 39
Seattle 39
Marseille 37
Los Angeles 34
Princeton 34
Nanjing 27
Chicago 25
Helsinki 25
Frankfurt am Main 24
Hefei 24
Houston 23
Jacksonville 23
Munich 22
Seoul 22
Woodbridge 22
Beijing 20
Brussels 20
Hong Kong 20
Hyderabad 20
Cambridge 19
North Bergen 17
Boardman 16
Nuremberg 16
Redmond 14
Turku 14
Hangzhou 13
Redwood City 13
Mountain View 12
Dearborn 11
London 11
Norwalk 11
São Paulo 11
Augusta 10
Lawrence 10
Vienna 10
Kunming 9
Nürnberg 9
Abidjan 8
Guangzhou 8
Izmir 8
Kish 8
Shanghai 8
Washington 8
West Jordan 8
Zhengzhou 8
Düsseldorf 7
Lauterbourg 7
Nanchang 7
Piacenza 7
Portsmouth 7
Santa Clara 7
Shenyang 7
Falkenstein 6
Falls Church 6
Fremont 6
Menlo Park 6
Ottawa 6
Andover 5
Belo Horizonte 5
Colombo 5
Lancaster 5
Montreal 5
Paris 5
Pune 5
Renton 5
Rio de Janeiro 5
University Park 5
Baghdad 4
Brooklyn 4
Campobasso 4
Cornaredo 4
Des Moines 4
Hebei 4
Lappeenranta 4
Leawood 4
Mumbai 4
Palermo 4
Sakaemachi 4
Toronto 4
Zurich 4
Bandung 3
Bari 3
Brno 3
Totale 2.624
Salva come PNG Salva come JPEG
Nome #
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 244
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 240
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 155
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 140
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 139
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 106
The Changing Clinical Spectrum of Hypophysitis 104
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 101
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 101
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 99
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 99
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 93
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 84
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 78
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 77
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 71
Empty sella syndrome: Multiple endocrine disorders. 70
Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice 70
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 70
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 69
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 67
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 67
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 67
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 65
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 65
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 65
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 63
Understanding the effect of acromegaly on the human skeleton. 61
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 60
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 60
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 60
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 60
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 60
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 57
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 57
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 56
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature 56
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 54
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 52
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 51
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 51
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 50
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 50
Acromegaly can be cured by first-line pasireotide treatment? 49
Acromegaly in the elderly patients 49
Hypothalamitis and pituitary atrophy 49
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship 45
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 44
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 42
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 40
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 35
Interpretable Machine Learning-Based Prediction of Intraoperative Cerebrospinal Fluid Leakage in Endoscopic Transsphenoidal Pituitary Surgery: A Pilot Study 34
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 34
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy 32
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 31
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 30
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 28
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 28
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 26
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 25
De-escalation treatment with pasireotide for acromegaly: a long-term experience 25
Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery 24
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 24
Consensus on criteria for acromegaly diagnosis and remission 24
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 23
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 22
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 21
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 19
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 19
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 19
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool 15
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management? 15
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 14
Temporoparietal Fascia Flap (TPFF) in Extended Endoscopic Transnasal Skull Base Surgery: Clinical Experience and Systematic Literature Review 11
The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency 11
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 11
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 11
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 11
Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice 9
Topography and Radiological Variables as Ancillary Parameters for Evaluating Tissue Adherence, Hypothalamic-Pituitary Dysfunction, and Recurrence in Craniopharyngioma: An Integrated Multidisciplinary Overview 9
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 8
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 5
null 4
Totale 4.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 0 0 0 0 0 0 27 12
2020/2021199 13 16 9 18 23 11 23 2 26 28 28 2
2021/2022474 20 11 6 37 76 25 9 85 23 21 54 107
2022/20231.087 132 153 78 190 56 161 61 78 103 19 27 29
2023/2024658 31 121 23 31 35 113 28 10 39 40 85 102
2024/20251.366 37 42 122 81 91 70 38 54 237 193 401 0
Totale 4.539